Onderzoeksoutput per jaar
Onderzoeksoutput per jaar
Onderzoeksoutput
- 12 resultaten
Zoekresultaten
-
2023
1136P Regorafenib combined with BRAF-/MEK-inhibitors for the treatment of refractory melanoma brain metastases
Dirven, I., Vander Mijnsbrugge, A-S., Tijtgat, J., Vounckx, M. & Neyns, B., okt 2023.Onderzoeksoutput: Poster
-
Neurocognitive Functioning in Metastatic Cancer Survivors Treated With Immune Checkpoint Blockade: First Results of A Single Center Cohort Study
Vanlaer, N., Kyndt, D., Van Eycken, S., Tijtgat, J., Kessels, J., Dirven, I., Vounckx, M., Neyns, B. & Rogiers, A., 31 jan 2023.Onderzoeksoutput: Poster
-
-
2022
A phase I clinical trial on intracranial administration of autologous myeloid dendritic cells (myDC) in combination with ipilimumab and nivolumab in patients with recurrent glioblastoma (rGB)
Schwarze, J. K., Geens, W., Tijtgat, J., Awada, G., Vanbinst, A., Everaert, H., Seynaeve, L., Michotte, A., Bruneau, M., VAN RIET, I., Tuyaerts, S., Duerinck, J. & Neyns, B., 3 jun 2022.Onderzoeksoutput: Poster
-
A phase I clinical trial on the intracranial administration of increasing doses of ipilimumab plus fixed dose nivolumab in patients with recurrent glioblastoma (rGB).
Geens, W., Schwarze, J. K., Tijtgat, J., Lescrauwaet, L. C., Tuyaerts, S., Geeraerts, X., Stevens, L., Vanbinst, A., Everaert, H., Bruneau, M., Duerinck, J. & Neyns, B., 2022.Onderzoeksoutput: Poster
-
Early interim results from a randomized phase II clinical trial of stereotactic body radiation therapy (SBRT) and systemic pembrolizumab with or without intratumoral avelumab/ipilimumab plus CD1c (BDCA-1)+/CD141 (BDCA-3)+ myeloid dendritic cells in non-small cell lung cancer (NSCLC)
Tijtgat, J., Schwarze, J. K., Vandenbroucke, F., Ilsen, B., Tuyaerts, S., Dufait, I., Decoster, L., De Ridder, M. & Neyns, B., 22 sep 2022.Onderzoeksoutput: Poster
-
HSV-1-derived oncolytic virus encoding FLT3L in combination with conventional dendritic cells: a potential combination for melanoma patients
Tuyaerts, S., Reale, A., Tijtgat, J., Geeraerts, X., Nedyalkova, S., Calistri, A. & Neyns, B., 16 jun 2022, (Unpublished).Onderzoeksoutput: Poster
-
-
Repeated intracranial administration of ipilimumab and nivolumab in patients with recurrent glioblastoma (rGB): A multi-cohort adaptive phase I clinical trial
Geens, W., Schwarze, J. K., Tijtgat, J., Lescrauwaet, L. C., Geeraerts, X., Vaeyens, F., Vanbinst, A., Everaert, H., Michotte, A., Cauwenbergh, T., Bruneau, M., Tuyaerts, S., Neyns, B. & Duerinck, J., 5 sep 2022, blz. ii38-ii39.Onderzoeksoutput: Poster
-
2021
371P - Low-dose bevacizumab for the treatment of focal post-radiation necrosis of the brain
Tijtgat, J., Schwarze, J. K. & Awada, G., 16 sep 2021.Onderzoeksoutput: Poster
-
S1-28 The oncolytic HSV-1 virus T-VEC induces immunogenic cell death of melanoma cells and efficiently matures monocyte derived as well as BDCA-1+/BDCA-3+ myeloid dendritic cells
De Munck, J., Kalus, P., Smets, H., Broos, K., Tijtgat, J., Van Riet, I., Dufait, I., Schwarze, J. K., Goyvaerts, C., Neyns, B., Tuyaerts, S., Breckpot, K. & Aerts, J., 10 mei 2021.Onderzoeksoutput: Poster
-
S2-106 Talimogene laherparepvec (T-VEC)-induced tumor oncolysate as a source of tumor antigens and maturation factors for blood-isolated myeloid dendritic cells
Tijtgat, J., De Munck, J., Dufait, I., Schwarze, J. K., Breckpot, K., Neyns, B., Aerts, J. & Tuyaerts, S., 11 mei 2021.Onderzoeksoutput: Poster
Bestand16 Downloads (Pure)